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ABSTRACT 
This study aimed to examine the effect of L-ornithine 
hydrochloride ingestion on serum growth hormone 
secretion response after strength training in young 
men who did not regularly engage in high intensity 
exercise. Ten healthy young males without workout 
habits (age: 22.2 +/- 1.0 yr). Subjects performed bi-
ceps curl strength training after L-ornithine hydro- 
chloride and placebo ingestions. They participated in 
both of the above conditions randomly with a week 
interval in between. Serum growth hormone and or-
nithine levels were measured before L-ornithine hy-
drochloride or placebo ingestions and at 30 minutes 
after strength training. Serum growth hormone and 
ornithine level were measured. A change magnitude 
of serum growth hormone was significantly larger in 
the L-ornithine hydrochloride condition than in the 
placebo condition, and the effect size was also large (t 
= 1.91, p = .044, ES = .75). A significant interaction (F 
= 280.98, p = 0.000, ηp2 = 0.96) was found in serum 
ornithine and a multiple comparison test showed that 
it was greater in the L-ornithine hydrochloride con-
dition. Serum growth hormone level after strength 
training increases by L-ornithine hydrochloride in-
gestion in untrained young males. 
 
Keywords: L-Ornithine Hydrochloride; Growth  
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1. INTRODUCTION 
Many athletes ingest amino acids such as arginine, or-
nithine, methionine and lysine to make the secretion of 
growth hormone accelerate before training. The growth 
hormone is essential to gain benefits from training such 
as increasing muscle mass and strength due to causing 
anabolic action. In other words, ingestion of these spe-
cial amino acids is based on the idea that training bene-
fits can be effectively gained by stimulating growth 
hormone secretion. 
Until now, the relatively larger growth hormone secre-
tion effect (800-2200%) by intravenous infusion of spe-
cial amino acids has been found [1-3]. However, all 
amino acids did not always show hormone secretion 
effect by intravenous infusion or oral ingestion. For ex-
ample, it was reported that branched-chain amino acids 
(BCAA) such as leucine and varine showed a slight 
growth hormone secretion effect (10%), and isoleucine 
had no effect [1]. Moreover, it was reported also that 
aspartic acid, glutamic acid and cysteine stimulated little 
growth hormone secretion [4]. Of the amino acids which 
showed a growth hormone secretion effect, arginine, 
lysine and ornithine are believed to be superior in stimu-
lating growth hormone secretion [3]. 
However, amino acids are not generally injected in-
travenously, but are instead ingested orally at training 
sites. Until now, arginine and ornithin have been mainly 
used to examine the effect on growth hormone secretion 
by oral amino acid ingestion [5-10]. However, there 
were mixed reports on the effect of growth hormone 
secretion by ornithine ingestion (negative reports: 5-9, 
Positive reports: 9, 10). One of the reasons for this large 
difference is considered to be the different ornithine 
amounts ingested. Subjects ingested over 170 mg per 
kilogram of body mass in Bucci et al. [10] and Cynober 
et al. [9]’s study, who reported positive effect, but sub-
jects ingested no more than 100mg per kilogram of body 
mass in the other studies. Moreover, subjects in all stud-
ies were mainly body builders or weight lifters who rou-
tinely conducted high intensity strength training. Muscle 
fibers of these subjects were larger than average people 
and it is inferred that a size of their muscle cells had ap-
proached the biological limit. The degree of growth 
hormone effect causing muscle fiber hypertrophy de-
pends on the level of growth hormone released in the 
blood and the activity level of the receptors. However, in 
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the body builders and weight lifters, because muscle 
fibers affected by growth hormone have approached the 
biological limit, receptor responses to an increase of 
growth hormone levels are small and the effect of or-
nithine ingestion on growth hormone secretion may be 
different.  
Recently many people have begun conducting training 
for maintaining/enhancing health, and many of them 
actively ingest nutriceutical products to efficiently gain 
training benefits. Ornithine is also one of the typical 
nutriceutical products, and the growth hormone secretion 
effect has been expected by its oral ingestion. However, 
it has not been clarified whether a growth hormone se-
cretion effect is also obtained in average people who do 
not have strenuous training habits as well as body build-
ers and weight lifters. 
This study aimed to examine the effect of L-ornithine 
hydrochloride ingestion on serum growth hormone se-
cretion response after strength training in young men 
who do not regularly engage in high intensity exercise. 
2. METHODS 
2.1. Subjects 
Ten healthy young adults who did not regularly engage 
in high intensity training participated in this study (age: 
22.2 +/- 1.0 yr, height: 173.5 +/- 4.6 cm, body-mass: 
72.5 +/- 12.5 kg). Written informed consent was ob-
tained from all subjects after a full explanation of the 
experimental purpose and protocol. Moreover, experi-
mental protocol in this study was approved by the in-
quiry committee of studies intended for humans” Kana-
zawa University Health & Sports Science Ethics Com-
mittee”. 
2.2. Experimental Design 
The experimental design was a double blinded 
cross-over method. Namely, subjects participated in 
both conditions of L-ornithine hydrochloride and pla-
cebo (indigestible dextrin aqueous solution) ingestions. 
Due to the cross-over design, all subjects participated 
in both conditions at the same time with washing out 
period of a week. The test order was also counter bal-
anced to eliminate order effect. In addition, subjects 
were prohibited from intensive exercise 2 days prior to, 
and to fast for at least two hours before, starting exer-
cise in order to avoid a nutritional imbalance with eat-
ing and drinking. Subjects were also instructed not to 
consume food or beverages that contain caffeine 
throughout the experimental period. 
2.3. Neutriceutical Products 
Subjects ingested L-ornithine hydrochloride or indi-
gestible dextrin aqueous solution with the same flavor 
(placebo) at the ratio of 0.1 g per body-mass. All neu- 
traceutical products were made by KYOWAHAKKO 
BIO Co., LTD. 
2.4. Procedure 
2.4.1. Determination of 1 Repetition Maximum 
One repetition maximum (RM) was measured for the 
subjects in advance in accordance with the procedure 
stated in Table 1 [11,12] to determine the strength train-
ing intensity in this study. 
2.4.2. Experimental Protocol and Procedure 
Subjects entered the laboratory and consumed L-or-
nithine hydrochloride or a placebo after baseline blood 
drawing. They conducted bicep curl strength training 
with 60% of 1RM intensity (Table 2) an hour after in-
gesting nutraceutical products. In addition, all sets re-
quired 10 repetitions and a 90 second rest was set be-
tween trials. The range of elbow joint motions for the 
concentric part was fully extended from 145 to 155°, 
flexed and means velocities for one repetition including 
concentric and eccentric motions were in a range of 
100-150°/s [13]. The second blood drawing was con-
ducted 30 minutes after the strength training. 
2.5. Parameters 
Serum ornithine and growth hormone levels before in-
gestion and after strength training were measured. 
Changes after the strength training were subtracted from 
the baseline values and used for an analysis of the 
growth hormone. 
 
Table 1. Procedure of 1RM measurement11,12. 
(1) Warm-up with a light resistance that easily allows 5-10 repeti-
tion; provide a 1 min rest. 
(2) Load increased 10-20% more than point 1 to allow 3-5 repeti-
tions to be completed; provide a 2 min rest period. 
(3) Load increased 10-20% more than point 2 to allow 2-3 repeti-
tions to be completed; provide a 2-4 min rest period. 
(4) Male a load increased of 10-20% more than point 3. Instruct 
the subject to attempt a 1RM. 
(5) If the subject is successful provide a 2-4 min rest and increase 
the load by 5-10% increase. If the subject is unsuccessful, provide 
a 2-4 min rest and decrease the load by 5-10%. 
(6) Continue point 5 until the subject can complete one repetition 
with proper exercise technique at the highest possible load. 
 
Table 2. Strength training protocol13. 
(1) Two sets of seated biceps curl at 60% of 2RM 
(2) Two sets of seated biceps curl at 60% of 1RM – 1 kg 
(3) Two sets of stamding biceps curl at 60% of 1RM – 2 kg 
(4) Two sets of stamding biceps curl at 60% of 1RM – 3 kg 
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The difference of serum ornithine level before ingestion 
and at 30 minutes after strength training between both 
conditions was tested by a paired two way analysis of 
variance. A Difference of variation in serum growth 
hormone in both conditions was tested by a paired t-test. 
Effect size was calculated by partial η2 (ηp2) and effect 
size (ES). In addition, an alpha level of .05 was used for 
all tests. 
2.6. Statistical Analysis 
3. RESULTS 
Figure 1 shows the results of the paired t-test between 
means of serum growth hormone in both conditions. A 
significant difference was found between both condi-
tions, and the L-ornithine hydrochloride condition was 
greater than the placebo condition and this difference 
was larger (t = 1.91, p = .044, ES = .75). Figure 2 shows 
the results of the two way analysis of variance for serum 
ornithine level. A significant interaction (F = 280.98, p = 
0.000, ηp2 = 0.96) was found in serum ornithine and a 
multiple comparison test showed that it was greater in 
the L-ornithine hydrochloride condition than in the pla-
cebo condition at 30 minutes after strength training. 
Moreover, serum ornithine level at 30 minutes after 
strength training was significantly greater than that be-
fore ingestion in L-ornithine hydrochloride ingestion. 
4. DISCUSSION 
The serum ornithine level at 30 minutes after strength 
training was greater in subjects ingesting L-ornithine 
hydrochloride than for subjects ingesting the placebo 
and this difference was large. Until now, it was reported 
that special amino acids such as ornthine and citruline 
were released and found at the peak level in the blood 
within 5-8 hours, being a relatively early time [8]. Ac-
cording to Cynober et al. [8], in the case of ornithine, 
blood concentration reaches a peak value at about 60 
minutes after oral ingestion. Serum ornithine level after 
L-ornithine hydrochloride ingestion in this study was 
very high although 120 minutes elapsed after ingestion 
(about 300 nmol/l, 500% increase as compared with be-
-fore ingestion). Increasing the amount of growth hor-
mone level before ingestion to 30 minutes after strength 
training was also significantly greater in subjects ingest-
ing L-ornithine hydrochloride than in those ingesting the 
placebo and this difference was large (about 200%). 
Bucci et al. [10] compared blood growth hormone level 
before L-ornithine hydrochloride ingestion, 45 minutes 
and 90 minutes after ingestion under the conditions of 40, 
100 and 170 mg/kg body-mass ingestion using body 
builders. They reported that blood growth hormone level 
at 90 minutes after ingestion in the 170 mg/kg condition 
was significantly greater than that of the other conditions 
(about 150-300%), and also significantly greater than 
that before ingestion (about 350%). Although the physi-
cal characteristics and training habits of subjects, and 
ingestion amount of ornithine hydrochloride differed 
between the present study and Bucci et al. [10]’s study, 
growth hormone secretion effect by ornithine hydrochlo-
ride ingestion was found in both studies and the degree 
of secretion was also similar. Meanwhile, Lambert et al. 
[5] measured the blood growth hormone level every 30 
minutes for 3 hours for eight male body builders with a 
placebo, 2.4 g of arginine and lysine, 1.8 g of ornithine 
and tyrosine, and 20 g of beef extract ingestion after 8 
hours of fasting to examine the influence of amino acid 
such as ornithine ingestion on blood growth hormone 
level. They reported that little change in growth hor-
mone level was found in any case of amino acid inges-
tion. Fry et al. [7] conducted a weight lifting training 
experiment over a week with amino acid ingestion such 
as ornithine hydrochloride, arginine and branched-chain 
amino acid together for 28 weight lifters to examine the 
effect of high intensity training and ingestion of amino 
acid neutraceutical production on endocrine response 
and lifting performance. As a result, an increase of 
growth hormone was found by training with high inten-
sity, but not by amino acid. Although experimental pro-
tocol differed between the former study 10 and the latter 
two studies [5,7], considering the similarity of subjects’ 
characteristics, a difference in their results may be 
caused by the kind of ingested amino acid and/or the 
amount ingested. Until now, growth hormone secretion 
effect by intravenous infusion and oral ingestion was 
found by amino acid such as arginine, ornithine, me-
thionin and lysine in previous studies [1-3], but little by 
branched-chain amino acids such as aspartic acid, glu-
tamic acid, cysteine, cysteine, leucine, valine and isoleu-
cine [1,4]. Fogelholm et al. [6] compared blood growth 
hormone level over 24 hours after 2 g of arginine, or-
nithine or lysine for weight lifters to examine the effects 
of a small amount of amino acid ingestion on growth 
hormone secretion. They reported an insignificant in-
crease of blood growth hormone level was found after 
ingestion of any amino acid. Considering the above, 
studies by Fry et al. [7] and Lambert et al. [5], used not 
only amino acids such as ornithine, arginine, methionine 
and lysine, which indicate a growth hormone secretion 
effect, but also the branched-chain amino acids, glutamic 
acid and aspartic acid, which do not indicate such a 
growth hormone secretion effect. The former amino ac-
ids were reduced with the whole ingestion amount being 
less (less than 3 g). The amount administered may relate 
to the difference between Bucci et al. [10]’s results (over 
10 g) and the results of Fry et al. [7] and Lambert et al. 
[5]. 
Meanwhile, although marked growth hormone secre-
tion was not found after 100mg/kg body-mass ornithine 
hydrochloride ingestion in Bucci et al. [10]’s report, it 
should be noted that a significant increase was found 
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Figure 1. Variation of serum growth hormone level in both conditions*, 
significant difference was found between both conditions. 
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Figure 2. Serum ornithine level before ingestion and 30 min after strength 
training*, significant difference was found between before ingestion and 30 
min after strengthe training, significant difference was found between 
both conditions. 
 
after ingestion of similar ornithine hydrochloride density 
in the present results. The difference between these re-
sults is inferred to be caused by the difference in the 
subjects’ characteristics. Namely, although the present 
subjects had no exercise habits, the subjects in the pre-
vious studies that include Bucci et al. [10] were body 
builders or weight lifters who conducted strength train-
ing with high frequency and intensity. The difference in 
the subjects’ characteristics in both studies may be re-
lated to the difference in adjustment and sensitivity of 
their muscle cells to training stimulation. Generally, hy-
pertrophy of muscle fibers brought about by strength 
training is results from the following: effect of anabolic 
hormone such as growth hormone that secretes after 
strength training, and effect of satellite cells as stem cell 
existing between sarcolemmas assimirate with the exist-
ing muscle fiber [14,15]. Because muscle fibers of 
trained subjects are enlarged by repeated training stimu-
lation, the size of muscle cells is inferred to be close to 
the biological limit. Strength of growth hormone effect 
regarding muscle fibers hypertrophy depends on the 
growth hormone level released into the blood and activ-
ity level of the receptors. However, responses of recep-
tors to an increase of growth hormone level are inferred 
to be small in muscle fibers nearly enlarged to the bio-
logical limit. Namely, muscle hypertrophy of the trained 
subjects depends on the differentiation and disintegration 
of satellite cells with training stimulation rather than 
anabolic hormone secreted after training. Therefore, the 
present results may have been different from Bucci et al.’s 
results in spite of the same ornithine hydrochloride in-
gestion. Meanwhile, in the case of the present subjects 
without strength training habits, because activity level of 
receptors increases with an increase of blood growth 
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hormone level, adjustment to strength training may oc-
cur relatively smoothly. In addition, because the hyper-
trophy regarding satellite cells is expected, training ef-
fects can be obtained efficiently. From the above, it is 
considered that even in subjects without an exercise 
habit, a growth hormone secretion effect was obtained 
by ingestion of ornithine hydrochloride in lower 
amounts than the previous study (170 mg/kg body-mass) 
[10], which was reported to obtain a growth hormone 
secretion effect. However, Collier et al. [16] reported 
that gastrointestinal discomfort is often caused by spe-
cial amino acids such as ornithine and arginine and the 
degree of this discomfort is related to the amount in-
gested. Although a growth hormone secretion effect was 
found by a lower ingestion amount as compared with 
Bucci et al. [10]’s report in this study, six out of ten sub-
jects complained of gastrointestinal discomfort such as 
stomachache and diarrhea. Further studies may be re-
quired to examine the lower amount of ingestion that 
obtains growth hormone secretion effect without such 
gastrointestinal discomfort. 
5. CONCLUSIONS 
Blood growth hormone level increases after strength 
training by L-ornithine hydrochloride ingestion in un-
trained males. 
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